Market by Component (Storage, Transportation, Monitoring components), Pharma Type (Branded Drugs, Generic Drugs, OTC), Therapy Area (Communicable Diseases, Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Neurological Disorders, Pain Management, Respiratory Diseases, Other Therapy Areas), Logistics Type (Non-Cold Chain Logistics, Cold Chain Logistics) and Country Outlook | Forecast 2024-2032
According to Triton’s report, the Latin America pharmaceutical logistics market is estimated to advance with a CAGR of 7.01% during the forecast years 2024-2032.
Report scope can be customized per your requirements - Request Free Sample Report
The pharmaceutical distribution industry in Latin America is notably fragmented, comprising numerous small companies. Identifying a reliable distributor remains a significant challenge for pharmaceutical firms, necessitating a meticulous screening process. Despite these challenges, the region’s robust industry makes it an attractive market for ambitious pharmaceutical manufacturers and logistics companies. Besides, players from the US and Europe are keen to expand their reach in the region. For instance, DHL Supply Chain expanded its footprint in Mexico by acquiring New Transport Applications (NTA), a specialist in pharmaceutical and healthcare logistics, in 2022. Hence, such developments support the growth of the pharmaceutical logistics market.
The countries explored in this region comprise:
Brazil leads the pharmaceutical logistics market, obtaining $2596.25 million in 2023
As Brazil imports around 95% of the raw materials for medicine production, fluctuations in freight costs and the rising dollar have escalated production expenses. This surge in costs has led to significant price increases for finished pharmaceutical products.
In response to these challenges, Brazil implemented a national medicines reverse logistics system (MRLS) in 2020 to ensure the proper disposal and potential reuse of medicines. This initiative complements existing local systems, which further creates opportunities for pharmaceutical logistics companies.
According to the World Bank, Brazil allocates about 10.31% of its GDP to healthcare. Moreover, pharmaceutical exports reached approximately $1.1 billion in 2021. This increased spending on drugs and vaccines is fueling the expansion of the pharmaceutical logistics market.
Market Forecast for Mexico
According to the National Chamber of the Pharmaceutical Industry of Mexico, pharmaceutical production in Mexico saw around 36% increase in 2022, marking the first instance of double-digit growth in a decade. Additionally, the nation’s pharmaceutical industry has made impressive strides in export capabilities. In 2023, Mexico exported 165 out of the 350 critical pharmaceutical and active pharmaceutical ingredient (API) products identified by the International Trade Administration to the United States. Hence, all these developments are creating lucrative opportunities for pharmaceutical logistics companies to a large extent.
The market is branched into component, logistics type, therapy area, and pharma type. The component section further includes storage, monitoring components, and transportation.
The storage segment is a vital component of the pharmaceutical logistics market, comprising primarily warehouses and refrigerated containers. Warehouses serve as central hubs in the pharmaceutical supply chain, facilitating the efficient distribution of products. By connecting pharmaceutical manufacturers with healthcare providers, warehouses ensure the effective and secure distribution of medical goods. A heightened focus on the proper storage of temperature-sensitive supplements drives the growth of the storage segment.
The notable companies thriving in the pharmaceutical logistics market comprise Medline Industries LP, Kuehne + Nagel, Marken (Acquired by UPS), SEKO Logistics, and United Parcel Service (UPS).
Medline Industries LP, the largest privately-owned distributor and manufacturer of medical supplies, offers a diverse range of products, support services, and educational resources across the healthcare sector. Medline’s core team comprises clinicians, researchers, engineers, financial experts, and over 1,200 direct sales representatives. Headquartered in Northfield, Illinois, Medline has evolved into a leading supplier of clinical solutions and medical products, serving clients across multiple regions, including Latin America.
Latest from the Market:
In March 2024, Maersk collaborated with PUMA for the first semi-automated omni channel fulfillment distribution center in Chile.
KEY DELIVERABLES OF THE REPORT:
Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the pharmaceutical logistics market revenue growth in Latin America and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the Latin America pharmaceutical logistics market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA PHARMACEUTICAL LOGISTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE PHARMACEUTICAL LOGISTICS MARKET
2.1.1. IMPACT
OF COVID-19
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. KEY
BUYING IMPACT ANALYSIS
2.3.1. LOGISTICS
TYPE
2.3.2. SERVICES
OFFERED
2.3.3. MODE
OF TRANSPORTATION
2.3.4. APPLICATION
2.3.5. REGULATORY
COMPLIANCE
2.3.6. TECHNOLOGICAL
CAPABILITIES
2.3.7. COST
2.3.8. RELIABILITY
2.3.9. AGILITY
2.4. VALUE
CHAIN ANALYSIS
2.4.1. MANUFACTURING
2.4.2. STORAGE
2.4.3. TRANSPORTATION
2.4.4. DISTRIBUTION
2.4.5. MONITORING
COMPONENTS
2.4.6. CONSUMPTION
2.5. REGULATORY
OUTLOOK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. KEY
MARKET STRATEGIES
2.7.1. CONTRACTS
& PARTNERSHIPS
2.7.2. BUSINESS
EXPANSIONS & DIVESTITURES
2.7.3. ACQUISITIONS
& MERGERS
2.7.4. PRODUCT
LAUNCHES & DEVELOPMENTS
2.8. MARKET
DRIVERS
2.8.1. ESCALATING
DEMAND FOR TEMPERATURE-REGULATED SOLUTIONS
2.8.2. EXPANDING
OCEAN FREIGHT SERVICES
2.8.3. INCREASING
CONSUMER INCLINATION TOWARDS OVER-THE-COUNTER MEDICATIONS
2.9. MARKET
CHALLENGES
2.9.1. NECESSITY
FOR REAL-TIME TRANSPARENCY AND DEPENDABILITY
2.9.2. STRINGENT
REGULATORY MANDATES
2.10. MARKET
OPPORTUNITIES
2.10.1. RISING
OPPORTUNITIES IN CELL & GENE THERAPY LOGISTICS DUE TO INCREASED DEMAND
2.10.2. DIGITAL
TRANSFORMATION PAVING THE WAY FOR ADVANCEMENTS IN PHARMACEUTICAL LOGISTICS
2.10.3. GROWING
DEMAND FOR CLINICAL TRIAL LOGISTICS
2.11. ANALYST
PERSPECTIVE
3. LATIN
AMERICA PHARMACEUTICAL LOGISTICS MARKET - BY COMPONENT
3.1. STORAGE
3.2. TRANSPORTATION
3.3. MONITORING
COMPONENTS
4. LATIN
AMERICA PHARMACEUTICAL LOGISTICS MARKET - BY PHARMA TYPE
4.1. BRANDED
DRUGS
4.2. GENERIC
DRUGS
4.3. OTC
5. LATIN
AMERICA PHARMACEUTICAL LOGISTICS MARKET - BY LOGISTICS TYPE
5.1. NON-COLD
CHAIN LOGISTICS
5.2. COLD
CHAIN LOGISTICS
6. LATIN
AMERICA PHARMACEUTICAL LOGISTICS MARKET - BY THERAPY AREA
6.1. COMMUNICABLE
DISEASES
6.2. ONCOLOGY
6.3. DIABETES
6.4. CARDIOVASCULAR
DISEASES
6.5. AUTOIMMUNE
DISEASES
6.6. NEUROLOGICAL
DISORDERS
6.7. PAIN
MANAGEMENT
6.8. RESPIRATORY
DISEASES
6.9. OTHER
THERAPY AREAS
7. LATIN
AMERICA PHARMACEUTICAL LOGISTICS MARKET – BY COUNTRY OUTLOOK
7.1. BRAZIL
7.1.1. BRAZIL
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.2. MEXICO
7.2.1. MEXICO
PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
7.3. REST
OF LATIN AMERICA
7.3.1. REST
OF LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET FORECAST & PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. AGILITY
LOGISTICS
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. AP
MOLLER – MAERSK
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. CARDINAL
HEALTH INC
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. CENCORA
(AMERISOURCEBERGEN)
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. CEVA
LOGISTICS
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. DB
SCHENKER
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. DEUTSCHE
POST AG
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. DSV
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. FEDEX
CORPORATION
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. KUEHNE
+ NAGEL
8.10.1. OVERVIEW
8.10.2. PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY
CHALLENGES
8.11. MARKEN
(ACQUIRED BY UPS)
8.11.1. OVERVIEW
8.11.2. PORTFOLIO
8.11.3. KEY
STRENGTHS
8.11.4. 8KEY
CHALLENGES
8.12. MEDLINE
INDUSTRIES LP
8.12.1. OVERVIEW
8.12.2. PORTFOLIO
8.12.3. KEY STRENGTHS
8.12.4. KEY
CHALLENGES
8.13. SEKO
LOGISTICS
8.13.1. OVERVIEW
8.13.2. PORTFOLIO
8.13.3. KEY
STRENGTHS
8.13.4. KEY
CHALLENGES
8.14. UNITED
PARCEL SERVICE (UPS)
8.14.1. OVERVIEW
8.14.2. PORTFOLIO
8.14.3. KEY
STRENGTHS
8.14.4. KEY
CHALLENGES
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, HISTORICAL YEARS,
2020-2023 (IN $ MILLION)
TABLE 2: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, FORECAST YEARS, 2024-2032
(IN $ MILLION)
TABLE 3: LIST OF CONTRACTS &
PARTNERSHIPS
TABLE 4: LIST OF BUSINESS
EXPANSIONS & DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS
& MERGERS
TABLE 6: LIST OF NEW PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 7: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2024-2032 (IN $ MILLION)
TABLE 8: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2024-2032 (IN $ MILLION)
TABLE 9: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2024-2032 (IN $ MILLION)
TABLE 10: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2024-2032 (IN $ MILLION)
TABLE 11: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: KEY BUYING IMPACT
ANALYSIS
FIGURE 3: VALUE CHAIN ANALYSIS
FIGURE 4: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, 2023 & 2032 (IN %)
FIGURE 5: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)
FIGURE 6: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $ MILLION)
FIGURE 7: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN $
MILLION)
FIGURE 8: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY PHARMA TYPE, 2023 & 2032 (IN %)
FIGURE 9: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY BRANDED DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 10: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY GENERIC DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 11: LATIN AMERICA PHARMACEUTICAL
LOGISTICS MARKET, BY OTC, 2024-2032 (IN $ MILLION)
FIGURE 12: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY LOGISTICS TYPE, 2023 & 2032 (IN %)
FIGURE 13: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY NON-COLD CHAIN LOGISTICS, 2024-2032 (IN $
MILLION)
FIGURE 14: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COLD CHAIN LOGISTICS, 2024-2032 (IN $
MILLION)
FIGURE 15: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, 2023 & 2032 (IN %)
FIGURE 16: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COMMUNICABLE DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 17: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 18: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY DIABETES, 2024-2032 (IN $ MILLION)
FIGURE 19: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY CARDIOVASCULAR DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 20: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY AUTOIMMUNE DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 21: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY NEUROLOGICAL DISORDERS, 2024-2032 (IN $
MILLION)
FIGURE 22: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY PAIN MANAGEMENT, 2024-2032 (IN $ MILLION)
FIGURE 23: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY RESPIRATORY DISEASES, 2024-2032 (IN $
MILLION)
FIGURE 24: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY OTHER THERAPY AREAS, 2024-2032 (IN $
MILLION)
FIGURE 25: LATIN AMERICA
PHARMACEUTICAL LOGISTICS MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 26: BRAZIL
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 27: MEXICO
PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)
FIGURE 28: REST OF LATIN
AMERICA PHARMACEUTICAL LOGISTICS MARKET 2024-2032 (IN $ MILLION)